NUBEQA
Generic: darolutamide
- NDC
- 50419-395
- RxCUI
- 2180330
- Route
- ORAL
- ICD-10 indication
- C61
Affordability Check
How much will you actually pay for NUBEQA?
In 30 seconds, see every legitimate way to afford NUBEQA — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About NUBEQA
What is this medication?
Nubeqa is a prescription medicine used to treat adult men with two specific types of prostate cancer. It is indicated for non-metastatic castration-resistant prostate cancer, which is a stage where the cancer has not spread to other parts of the body but has stopped responding to hormone therapy. Additionally, it is used to treat metastatic hormone-sensitive prostate cancer when given in combination with a chemotherapy drug called docetaxel.
This medication belongs to a class of drugs known as androgen receptor inhibitors. It works by blocking the activity of hormones like testosterone that can cause prostate cancer cells to grow and divide. By interfering with the ability of these hormones to bind to receptors in the cancer cells, the drug helps to slow the growth of the tumor and delay the spread of the disease. It is administered as an oral tablet and is usually taken twice per day with food.
Copay & patient assistance
- Patient Copay Amount: As little as $0
- Maximum Annual Benefit Limit: $25,000 per year
- Core Eligibility Restrictions: Patients must have commercial insurance. Those enrolled in any type of government insurance or reimbursement programs (such as Medicare or Medicaid) are not eligible. Patients enrolled in the Bayer US Patient Assistance Foundation are also not eligible. Use of the program must not conflict with the patient's private insurance policy.
- RxBIN, PCN, and Group numbers: Not Publicly Available
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for darolutamide.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup NUBEQA →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for darolutamide →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How NUBEQA appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).
Covered by plans
62%
3,382 of 5,499 plans
Most common tier
Tier 5
On 79% of covering formularies
Prior authorization required
99%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 1 (preferred generic) | 59 | 18% |
| Tier 2 (generic) | 2 | 1% |
| Tier 4 (non-preferred brand) | 7 | 2% |
| Tier 5 (specialty) | 260 | 79% |
Step therapy: 0% of formularies
Quantity limits: 85% of formularies
Coverage breadth: 328 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
EVEROLIMUS
Treats same condition · Everolimus
AVMAPKI FAKZYNJA CO-PACK
Treats same condition · avutometinib potassium and defactinib hydrochloride
Fludeoxyglucose F18
Treats same condition · Fludeoxyglucose F18
Portrazza
Treats same condition · necitumumab
Pilocarpine Hydrochloride
Treats same condition · Pilocarpine Hydrochloride
TEPADINA
Treats same condition · THIOTEPA
AVGEMSI
Treats same condition · Gemcitabine
CLENPIQ
Treats same condition · SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
Niva Thyroid
Treats same condition · thyroid, porcine
Kisunla
Treats same condition · donanemab-azbt
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.